CD40 ligand (CD154) does not contribute to lymphocyte-mediated inhibition of virulent Mycobacterium tuberculosis within human monocytes

Infect Immun. 2002 Aug;70(8):4716-20. doi: 10.1128/IAI.70.8.4716-4720.2002.

Abstract

Human monocytes displayed increased expression of CD40 following infection with virulent Mycobacterium tuberculosis. Nevertheless, soluble CD40 ligand (CD40L; also designated CD154) had no effect on the intracellular growth of the organism. Restriction of the intracellular growth of M. tuberculosis by peripheral blood lymphocytes and antigen-specific CD4+ T-cell lines likewise was not reduced by blocking anti-CD40L monoclonal antibody 5c8.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Antibodies, Monoclonal / immunology
  • CD4-Positive T-Lymphocytes / cytology
  • CD4-Positive T-Lymphocytes / immunology
  • CD40 Antigens / biosynthesis
  • CD40 Antigens / immunology
  • CD40 Ligand / immunology*
  • CD40 Ligand / pharmacology
  • Cell Line
  • Humans
  • Intracellular Fluid / microbiology
  • Lymphocytes / cytology
  • Lymphocytes / immunology
  • Lymphocytes / microbiology
  • Middle Aged
  • Monocytes / immunology
  • Monocytes / microbiology
  • Mycobacterium tuberculosis / growth & development
  • Mycobacterium tuberculosis / immunology*
  • Recombinant Proteins / immunology
  • Recombinant Proteins / pharmacology
  • Virulence

Substances

  • Antibodies, Monoclonal
  • CD40 Antigens
  • Recombinant Proteins
  • CD40 Ligand